{
  "schema_version": "0.1.0",
  "id": "fda-drug-shortage:dobutamine-hydrochloride-injection",
  "slug": "dobutamine-hydrochloride-injection",
  "title": "FDA shortage status: Dobutamine Hydrochloride Injection",
  "ingredient": "Dobutamine Hydrochloride Injection",
  "status": "current",
  "source_statuses": [
    "Current",
    "To Be Discontinued"
  ],
  "brand_names": [
    "DOBUTAMINE",
    "DOBUTAMINE HYDROCHLORIDE IN DEXTROSE"
  ],
  "therapeutic_categories": [
    "Cardiovascular",
    "Pediatric",
    "Renal"
  ],
  "dosage_forms": [
    "Injection"
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "package_count": 11,
  "packages": [
    {
      "package_ndc": "0338-1073-02",
      "product_ndc": "0338-1073",
      "company_name": "Baxter Healthcare",
      "manufacturer_name": "Baxter Healthcare Corporation",
      "presentation": "Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 100 mg/100 mL (NDC 0338-1073-02)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "11/06/2017",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0338-1075-02",
      "product_ndc": "0338-1073",
      "company_name": "Baxter Healthcare",
      "manufacturer_name": "Baxter Healthcare Corporation",
      "presentation": "Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 200 mg/100 mL (NDC 0338-1075-02)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "11/06/2017",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0338-1077-02",
      "product_ndc": "0338-1073",
      "company_name": "Baxter Healthcare",
      "manufacturer_name": "Baxter Healthcare Corporation",
      "presentation": "Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/100 mL (NDC 0338-1077-02)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "11/06/2017",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70436-203-80",
      "product_ndc": "70436-203",
      "company_name": "Hainan Poly Pharm. Co., Ltd.",
      "manufacturer_name": "Slate Run Pharmaceuticals",
      "presentation": "Dobutamine Hydrochloride, Injection, 250 mg/20 mL (NDC 70436-203-80)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "05/08/2026",
      "initial_posting_date": "11/06/2017",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-3724-32",
      "product_ndc": null,
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": null,
      "presentation": "Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 1,000 mg/250mL (400 mg/mL) (NDC 0409-3724-32)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "08/07/2026",
      "initial_posting_date": "11/06/2017",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-2346-32",
      "product_ndc": null,
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": null,
      "presentation": "Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 250 mg/250mL (100 mg/mL) (NDC 0409-2346-32)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "08/07/2026",
      "initial_posting_date": "11/06/2017",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-2347-32",
      "product_ndc": null,
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": null,
      "presentation": "Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 500 mg/250mL (200 mg/mL) (NDC 0409-2347-32)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "08/07/2026",
      "initial_posting_date": "11/06/2017",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-2344-01",
      "product_ndc": "0409-2344",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "11/06/2017",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-2344-02",
      "product_ndc": "0409-2344",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-02)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "11/06/2017",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-2344-88",
      "product_ndc": "0409-2344",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-88)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "11/06/2017",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-2344-88",
      "product_ndc": "0409-2344",
      "company_name": "Pfizer Inc.",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Dobutamine Hydrochloride, Injection, 12.5 mg/1 mL (NDC 0409-2344-88)",
      "availability": null,
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/27/2025",
      "initial_posting_date": "08/27/2025",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    }
  ],
  "availability_counts": {
    "Available": 9,
    "Unavailable": 1
  },
  "initial_posting_date": "08/27/2025",
  "latest_source_update": "08/27/2025",
  "source_updated_at": "2026-08-22",
  "official_url": "https://api.fda.gov/drug/shortages.json",
  "source_name": "U.S. Food and Drug Administration openFDA Drug Shortages",
  "source_license_url": "https://open.fda.gov/license/",
  "retrieved_at": "2026-08-22T15:54:11+00:00",
  "unknowns": {
    "local_availability": "Unknown. FDA status is nationwide and is not local inventory.",
    "clinical_alternatives": "Not provided. CiteFacts does not publish treatment or substitution advice.",
    "resolution_date": "Unknown unless an FDA source row provides an update date."
  },
  "derivations": {
    "status": "current when a grouped FDA row has Current; otherwise it preserves the available FDA Resolved, Discontinuation, or not-current state.",
    "ingredient_page": "Grouped by FDA generic_name, falling back to openFDA.generic_name.",
    "availability_counts": "Count of non-empty FDA package availability values; it is not a claim about local supply."
  }
}